There are noFDAapproveddrugs to treathemorrhoidsWe expect tofinish theMino-Loktrial this yearMino-WrapI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.We haveenough cashto go wellinto 2023I/ONTAKis our leadassetMino-Lokpotentialmarket>$1BOnly biotechwith 2 Myron'son theleadershipteamWe intendto submita BLA in2H 2022The name Citiuscomes from theOlympic motto"Citius,AltiusForius"An actualiMSCupdateNot manycompaniesthis size with2 late stageassetsHemorrhoidsis a $2BmarketInsidersinvested$26.5mWe had aphase 2btrial with100%efficacyWe will openupinternationalsites forMino-Lok trialWe willhaveexclusivityMino-Lokis our leadassetI/ONTAKwas thebest deal Iever madeI/ONTAK'spotentialmarket is>$300mI won't diluteshareholdersMyron Holubiakand I founded aprivatecompany in2013Our Halo-Lido trial willhave finalpatient byend of 2022I'm ashareholdermyselfThere are noFDAapproveddrugs to treathemorrhoidsWe expect tofinish theMino-Loktrial this yearMino-WrapI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.We haveenough cashto go wellinto 2023I/ONTAKis our leadassetMino-Lokpotentialmarket>$1BOnly biotechwith 2 Myron'son theleadershipteamWe intendto submita BLA in2H 2022The name Citiuscomes from theOlympic motto"Citius,AltiusForius"An actualiMSCupdateNot manycompaniesthis size with2 late stageassetsHemorrhoidsis a $2BmarketInsidersinvested$26.5mWe had aphase 2btrial with100%efficacyWe will openupinternationalsites forMino-Lok trialWe willhaveexclusivityMino-Lokis our leadassetI/ONTAKwas thebest deal Iever madeI/ONTAK'spotentialmarket is>$300mI won't diluteshareholdersMyron Holubiakand I founded aprivatecompany in2013Our Halo-Lido trial willhave finalpatient byend of 2022I'm ashareholdermyself

Leonard Mazur HCW Conference BINGO - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. There are no FDA approved drugs to treat hemorrhoids
  2. We expect to finish the Mino-Lok trial this year
  3. Mino-Wrap
  4. I/ONTAK was previously approved but taken off the market to improve manufacturing.
  5. We have enough cash to go well into 2023
  6. I/ONTAK is our lead asset
  7. Mino-Lok potential market >$1B
  8. Only biotech with 2 Myron's on the leadership team
  9. We intend to submit a BLA in 2H 2022
  10. The name Citius comes from the Olympic motto "Citius,Altius Forius"
  11. An actual iMSC update
  12. Not many companies this size with 2 late stage assets
  13. Hemorrhoids is a $2B market
  14. Insiders invested $26.5m
  15. We had a phase 2b trial with 100% efficacy
  16. We will open up international sites for Mino-Lok trial
  17. We will have exclusivity
  18. Mino-Lok is our lead asset
  19. I/ONTAK was the best deal I ever made
  20. I/ONTAK's potential market is >$300m
  21. I won't dilute shareholders
  22. Myron Holubiak and I founded a private company in 2013
  23. Our Halo-Lido trial will have final patient by end of 2022
  24. I'm a shareholder myself